Ranjit Chima, MD, FAAP
- Medical Director, Division of Critical Care
- Medical Director, Destination Excellence
- Attending Physician, Pediatric Intensive Care Unit (PICU)
- Associate Professor, UC Department of Pediatrics
- ranjit.chima@cchmc.org
- Board Certified
About
Biography
As a pediatric critical care specialist, I care for children in the pediatric intensive care unit (PICU) at Cincinnati Children’s Hospital Medical Center.
I believe in listening to families and patients. I treat patients for who they are, no matter their diagnosis or disease.
My interest in taking care of the sickest children inspired me to work in critical care and the ICU. I am a board-certified pediatrician and pediatric intensivist with more than 10 years of experience working in the Cincinnati Children’s PICU.
I focus my work on patient care, clinical research, quality improvement and administration.
I have special interests in caring for patients with:
- Acute kidney injury (AKI)
- Critical illness after a stem cell transplant
- Extracorporeal life support (ECLS)
- Pediatric acute respiratory distress syndrome (ARDS)
- Traumatic brain injury (TBI)
I am active in clinical research. I serve as the site principal investigator/co-investigator for multiple National Institutes of Health (NIH)-sponsored clinical studies. My quality improvement efforts focus on leading Cincinnati Children’s work in mitigating hospital-acquired venous thromboembolism (blood clots).
At Cincinnati Children’s, I hold multiple leadership roles. I am the medical director of the Destination Excellence International Patient Program which coordinates referrals and care for international patients. I'm the associate medical director of the PICU, and co-director of the Center for Acute Care Nephrology and the extracorporeal life support (ECLS) program.
I also serve as an associate professor in the Division of Critical Care Medicine in the Department of Pediatrics at Cincinnati Children’s and the University of Cincinnati College of Medicine.
In my free time I love to cook and golf.
MBBS: Grant Medical College, Mumbai, India, 1996.
MD: Pediatrics, University of Mumbai, Mumbai, India, 1999.
Residency: Pediatrics, University of Mumbai, Mumbai, India, 1996-1999; Pediatrics, Children's Hospital of Michigan, Detroit, MI, 2001-2004.
Fellowship: Pediatric Critical Care Medicine, Cincinnati Children's Hospital Medical Center, 2004-2007.
Certification: Pediatrics, 2004, 2014; Pediatric Critical Care Medicine, 2008.
Interests
Critical Illness following stem cell transplantation; extracorporeal life support; venous thromboembolism; critical Illness hyperglycemia
Services and Specialties
Interests
Research Areas
Additional Languages
Hindi, PunjabiPublications
MRI and Clinical Variables for Prediction of Outcomes After Pediatric Severe Traumatic Brain Injury. JAMA network open. 2024; 7:e2425765.
Elucidating a genomic signature associated with behavioral and executive function after moderate to severe pediatric TBI: a systems biology informed approach. Frontiers in Systems Biology. 2024; 4:1293265.
Immunocompromised-Associated Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study. Pediatric Critical Care Medicine. 2024; 25:288-300.
Real-Time Acute Kidney Injury Risk Stratification-Biomarker Directed Fluid Management Improves Outcomes in Critically Ill Children and Young Adults. Kidney International Reports. 2023; 8:2690-2700.
Use of design thinking and human factors approach to improve situation awareness in the pediatric intensive care unit. Journal of hospital medicine (Online). 2023; 18:978-985.
Rapidly Progressive Respiratory Failure and Shock in a Healthy Teenager. Pediatrics in review / American Academy of Pediatrics. 2023; 44:S77-S80.
Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series. Critical Care Explorations. 2023; 5:e0978.
Tight Glycemic Control, Inflammation, and the ICU: Evidence for Heterogeneous Treatment Effects in Two Randomized Controlled Trials. American Journal of Respiratory and Critical Care Medicine. 2023; 207:945-949.
A risk-stratified assessment of biomarker-based acute kidney injury phenotypes in children. Pediatric Research. 2023; 93:1354-1360.
Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children's Hospital. The Pediatric Infectious Disease Journal. 2023; 42:119-121.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey